针对淋巴瘤青少年和年轻成年人的群体支持干预:试点随机对照试验
Dalnim Cho1, Sairah Ahmed1, Stella Snyder1
1The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Psycho-oncology
|November 26, 2025
概括
通过视频会议进行的以小组为基础的冥想和教育干预措施对于淋巴瘤的青少年和年轻人来说是可行的. 心理教育组在减少与癌症相关的症状负担方面表现出显著的改善.
科学领域:
- 在瘤学瘤学.
- 心理社会瘤学
- 提供癌症护理 提供癌症护理
背景情况:
- 淋巴瘤是青少年和年轻人 (AYA) 中常见的一种癌症.
- 支持性护理干预对于管理淋巴瘤AYA患者的心理痛苦和症状至关重要.
- 对这一群体进行虚拟的,以群体为基础的干预措施的可行性需要调查.
研究的目的:
- 评估两种基于小组的干预措施 (冥想和精神教育) 的可行性,以帮助患有淋巴瘤的AYA.
- 探索这些干预措施在减少心理痛苦和癌症相关症状负担方面的潜在好处.
- 评估虚拟交付在可访问性和可扩展性方面的有效性.
主要方法:
- 随机对照试验涉及AYA (18-39岁) 接受化疗的淋巴瘤患者.
- 干预措施:每周5次60分钟的会议通过视频会议进行 (冥想与精神教育).
- 在基线,6周和12周进行评估,以衡量可行性,出席率,保留率和症状负担.
主要成果:
- 通过51.4%的同意率和跨组可比的会议出席率证明了可行性.
- 从基线到12周,精神教育干预组在与癌症相关的症状严重程度和干扰方面显示出统计学上显著的改善.
- 评估完成率通常很高,这表明参与者参与.
结论:
- 通过视频会议提供,以小组为基础的支持性护理在积极治疗期间对淋巴瘤的AYA是可行的.
- 这些干预措施可能有助于减少症状负担并保持生活质量.
- 增强坚持和保留的策略是必要的,以优化参与这一群体.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Community Based Intervention
262
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
262
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Bioavailability Study Design: Healthy Subjects Versus Patients
136
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
136


